leukoplakia

Leukoplakia is a chronic disease characterized by excessive growth of squamous epithelium of the mucous membrane, most often of the oral cavity or genitals. A sign of leukoplakia is the formation of whitish, pronounced areas on the mucous membranes that do not disappear when injured and may be accompanied by itching or burning. The disease can also be associated with precancerous conditions and requires careful monitoring. The main pathogenesis of leukoplakia includes disturbances in keratinization processes and increased production of epithelial cells in response to various irritants, which can lead to abnormal changes in the cellular structure.

History of the disease and interesting historical facts

Leukoplakia was first described in medical literature in the 19th century. Since then, physicians and researchers have conducted numerous studies to understand the nature of this condition and its relationship with cancer. The term leukoplakia comes from the Greek words leukos (white) and plakos (plate), which describe the appearance of the affected areas. Interestingly, in the late 19th century, leukoplakia became the subject of intense debate among medical researchers regarding its etiology and pathogenesis. One of the most famous cases is the description of leukoplakia in patients who used tobacco, which subsequently led to the association of the disease with exogenous risk factors.

Epidemiology

The epidemiology of leukoplakia shows a diversity of incidence depending on age groups, gender, and geographic location. According to various studies, the prevalence of leukoplakia among men is about 3:1 compared to women. Higher incidence is observed in smokers and people with poor oral hygiene. According to statistics, in some populations, the prevalence can reach 2-5% among adults. It is noteworthy that in most cases, leukoplakia does not cause symptoms, which complicates diagnosis and can lead to delayed seeking medical care.

Genetic predisposition to this disease

Studies of genetic predisposition to leukoplakia have identified several genes associated with the disease. The most notable are mutations in genes responsible for the processes of proliferation and keratinization of epithelial cells. For example, mutations in the TP53 and CCND1 genes, which are associated with the regulation of the cell cycle and apoptosis, are assumed to have an effect. Studies also show that polymorphisms in genes responsible for toxin metabolism may increase the likelihood of developing leukoplakia among smokers. These data indicate a possible role of genetic factors in predisposition to the disease.

Risk factors for the development of this disease

Leukoplakia is associated with several physical and chemical risk factors:

• Tobacco use (smoking and chewing tobacco)
• Alcohol abuse
• Chronic irritation of the mucous membrane (eg, from dentures or sharp edges of teeth)
• Poor oral hygiene
• Viral infections (such as human papillomavirus)

Other risk factors include immunodeficiency conditions and genetic predisposition, which may increase the susceptibility of patients to the disease. Each of these conditions or habits can affect the homeostasis of the mucous membrane, contributing to the development of leukoplakia.

Diagnosis of this disease

Diagnosis of leukoplakia includes several key stages:

• Main symptoms: Leukoplakia may present as whitish patches on the mucous membranes, which may be asymptomatic or accompanied by itching and burning.
• Laboratory research: It is important to perform cytological examination of a tissue sample from the affected area to assess the cellular composition.
• Radiological examinations: Rarely used, but can be used to rule out other diseases.
• Other types of diagnostics: It is important to perform a biopsy for morphological examination to exclude associated pathological changes such as dysplasia.
• Differential diagnosis: Leukoplakia should be distinguished from other diseases such as candidiasis, lycopene planus, and mucosal cancer.

Treatment

Treatment approaches for leukoplakia depend on its severity and possible associated diseases. In most cases, general treatment is initially used, which includes:

• Lifestyle changes (quitting smoking and drinking alcohol)
• Ensuring proper oral hygiene

Pharmacological treatment includes:

• Use of corticosteroids to reduce inflammation
• Immunomodulatory drugs, if there is a need to correct the immune response

In the presence of precancerous changes, surgical treatment may be required:

• Removal of diseased tissue to prevent progression to cancer

There are also other treatments, such as laser therapy, that can be used to remove areas of leukoplakia while sparing healthy tissue.

List of drugs used to treat this disease

Among the drugs that can be used to treat leukoplakia are:

• Corticosteroids (eg, betamethasone)
• Immunomodulators (eg, azathioprine)
• Vitamin preparations (for example, vitamin A and its derivatives)
• Antibiotics in case of secondary infection (eg, metronidazole)

Disease monitoring

Monitoring leukoplakia is important to prevent it from progressing and becoming cancerous. Examinations are performed at regular intervals:

• Initial examination by a dentist or dermatologist
• Cytological examination (every 6-12 months)
• Photographic monitoring of changes

The prognosis of the disease is favorable in most cases, provided it is detected and treated in a timely manner. However, if preventive measures are not followed and risk factors are present, complications such as oral cancer are possible.

Age-related features of the disease

Leukoplakia can manifest itself in different age groups, but is most often observed in elderly patients. Benign forms of the disease are more common in young people, while precancerous changes are more common in older people. Women with leukoplakia may experience a more pronounced course of the disease during menopause, which is associated with changes in hormonal levels. In children, leukoplakia is extremely rare and is usually associated with congenital anomalies or chronic immune system disorders.

Questions and Answers

• What is leukoplakia?
  Leukoplakia is a chronic disease characterized by the formation of whitish areas on the mucous membranes, often associated with precancerous changes.
• What are the main causes of leukoplakia?
  The main causes include smoking, alcohol consumption and chronic irritation of the mucous membrane.
• How is leukoplakia diagnosed?
  Diagnosis is made on the basis of clinical examination, cytological examination and, if necessary, biopsy.
• How is leukoplakia treated?
  Treatment may include lifestyle changes, medications, and, in some cases, surgery.
• What is the prognosis for leukoplasia?
  The prognosis is favorable with timely diagnosis and treatment, but constant monitoring is required to prevent complications.